BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 36579676)

  • 1. Blocking the Wnt/β‑catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies (Review).
    Chen Y; Chen M; Deng K
    Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36579676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic strategies targeting Wnt/β‑catenin signaling for colorectal cancer (Review).
    Ji Y; Lv J; Sun D; Huang Y
    Int J Mol Med; 2022 Jan; 49(1):. PubMed ID: 34713301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleckstrin 2 is a potential drug target for colorectal carcinoma with activation of APC/β‑catenin.
    Chai B; Guo Y; Zhu N; Jia J; Zhang Z; Ping M; Jia K; Cui X; Suo Y
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34676872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of LDOC1 on colorectal cancer cells via downregulation of the Wnt/β-catenin signaling pathway.
    Jiang J; Li Y; Jiang Z
    Oncol Rep; 2019 Jun; 41(6):3281-3291. PubMed ID: 31002361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
    Cheng X; Xu X; Chen D; Zhao F; Wang W
    Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IPO11 mediates βcatenin nuclear import in a subset of colorectal cancers.
    Mis M; O'Brien S; Steinhart Z; Lin S; Hart T; Moffat J; Angers S
    J Cell Biol; 2020 Feb; 219(2):. PubMed ID: 31881079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA‑8063 targets heterogeneous nuclear ribonucleoprotein AB to inhibit the self‑renewal of colorectal cancer stem cells via the Wnt/β‑catenin pathway.
    Chen ZQ; Yuan T; Jiang H; Yang YY; Wang L; Fu RM; Luo SQ; Zhang T; Wu ZY; Wen KM
    Oncol Rep; 2021 Oct; 46(4):. PubMed ID: 34396427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pimozide suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling pathway.
    Ren Y; Tao J; Jiang Z; Guo D; Tang J
    Life Sci; 2018 Sep; 209():267-273. PubMed ID: 30107167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt/β‑catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer (Review).
    Zhu GX; Gao D; Shao ZZ; Chen L; Ding WJ; Yu QF
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR‑501‑3p promotes colorectal cancer progression via activation of Wnt/β‑catenin signaling.
    Wu F; Xing T; Gao X; Liu F
    Int J Oncol; 2019 Sep; 55(3):671-683. PubMed ID: 31364752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forkhead Box S1 mediates epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway to regulate colorectal cancer progression.
    Zhang L; Ren CF; Yang Z; Gong LB; Wang C; Feng M; Guan WX
    J Transl Med; 2022 Jul; 20(1):327. PubMed ID: 35864528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GANT61 exerts anticancer cell and anticancer stem cell capacity in colorectal cancer by blocking the Wnt/β‑catenin and Notch signalling pathways.
    Si Y; Li L; Zhang W; Liu Q; Liu B
    Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36069229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXD1 promotes chemotherapy resistance by enhancing cell stemness in colorectal cancer through β‑catenin nuclear localization.
    Feng WQ; Zhang YC; Gao H; Li WC; Miao YM; Xu ZF; Xu ZQ; Zhao JK; Zheng MH; Zong YP; Lu AG
    Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37203394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor microenvironment involvement in colorectal cancer progression
    Novoa Díaz MB; Martín MJ; Gentili C
    World J Gastroenterol; 2022 Jul; 28(26):3027-3046. PubMed ID: 36051330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FUT2 promotes the tumorigenicity and metastasis of colorectal cancer cells via the Wnt/β‑catenin pathway.
    Liu P; Liu J; Ding M; Liu Y; Zhang Y; Chen X; Zhou Z
    Int J Oncol; 2023 Mar; 62(3):. PubMed ID: 36734282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR‑576‑5p promotes epithelial‑to‑mesenchymal transition in colorectal cancer by targeting the Wnt5a‑mediated Wnt/β‑catenin signaling pathway.
    Luo J; Liu L; Shen J; Zhou N; Feng Y; Zhang N; Sun Q; Zhu Y
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiRNA-Wnt signaling regulatory network in colorectal cancer.
    Jafarzadeh M; Soltani BM
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22883. PubMed ID: 34382723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-155 enhances the activation of Wnt/β-catenin signaling in colorectal carcinoma by suppressing HMG-box transcription factor 1.
    Wan YC; Li T; Han YD; Zhang HY; Lin H; Zhang B
    Mol Med Rep; 2016 Mar; 13(3):2221-8. PubMed ID: 26780942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
    Song L; Li Y; He B; Gong Y
    Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.